TENX: Guggenheim Raises PT
Guggenheim maintains buy rating on Tenax Therapeutics and raises price target to $40
Guggenheim Maintains Buy on Tenax Therapeutics, Raises Price Target to $40
Guggenheim maintains buy rating on Tenax Therapeutics and raises price target to $40
Guggenheim Maintains Buy on Tenax Therapeutics, Raises Price Target to $40